web analytics
1.3 C
Munich
Sunday, November 27, 2022

The Exciting Rise of Oxi Thyme; Rising Biosciences Inc (OTCMKTS: RBII)

Rising Biosciences Inc (OTCMKTS: RBII) is heating up and moving steadily higher in recent trading as new investors accumulate and discover the exciting Oxi Thyme story. The Company has been making big moves too recently announcing it is currently in contract negotiations with a health care group with over 300 facilities and involved in talks with several grocery retailers. RBII CEO Arthur Hall said on having a stable supply chain is a valuable competitive edge. “While larger companies are trying to limit quantities, we can provide what the customer needs now.”

RBII has been skyrocketing up the charts in recent weeks as its Oxi Thyme “it’s time to clean” gains serious traction. Described by many as the best and most affordable sanitization and disinfectant product on the market – All natural, EPA and CDC approved, Oxi Thyme utilizes an atomizing ULV (ultra-low volume) or HVLP (high volume, low pressure) fogging system which allows droplets of disinfectant to disperse more evenly and cover larger surface areas, creating a no touch solution to sanitize large areas quickly and efficiently leaving no toxic residue. In July RBII reportes significant revenue growth to nearly $350,000 in Q2 as sales and reception of the company’s Oxi Thyme have escalated dramatically. The story has been getting picked up by mainstream press and RBII has started booking significant sales.

Rising Biosciences Inc (OTCMKTS: RBII) operating out of Sandusky, Ohio operates three distinct business units in addition to Oxi Thyme. The first business unit is a physicians practice management company focused on the proper use of cannabis for the treatment of chronic pain, opioid addiction, and terminal patients. The second business unit is a research and development company focusing on oral and topical pharmaceuticals within the strict standards set forward by the pharmaceutical compounding industry and the FDA. The third business unit offers cutting edge behavioral health medical treatment for substance addiction from branches throughout the Midwest.

Earlier this year RBII reported the production launch of Oxithymol™ a proprietary, non-toxic, blended formula of CDC approved hydrogen peroxide, thymol and other natural, environmentally safe ingredients. Oxithymol™ disinfectant solution is applied via the Oxi Thyme™ atomizing ULV/HPLV fogging system. The “no touch” system is effective in killing disease-causing microbial pathogens on hard surfaces, and is suitable for residential, commercial and automotive settings. RBII joined a number of other regional manufacturers, in responding to Governor DeWine’s appeal.

To Find out the inside Scoop on RBII  subscribe to Microcapdaily.com Right Now by entering your Email in the box below

RBII

On August 5 RBII CEO Arthur Hall said in a press release that as the large disinfectant manufacturers are reporting supply chain problems, RBII has no similar issues and is meeting customers’ needs. Mr. Hall further stated the Company is currently in contract negotiations with a health care group with over 300 facilities and involved in talks with several grocery retailers.

Mr. Hall stated: “Other larger companies have reported their supply chains are stressed. This kind of news has understandably concerned our current and pending customers. Rising Biosciences is not experiencing supply issues. We are in full production in our Ohio facility, adding two additional lines there and also starting production soon in Florida. We are reassuring our customers that we don’t expect any supply interruptions.  Being a smaller company gives us some rather distinct advantages. We can pivot easily and react faster, providing more immediate solutions in this challenging environment. This Covid-19 pandemic is a moving target, affecting our daily lives and posing uncertainties about the future, both short and long term. We are extremely confident in our ability to maintain current production levels and quickly ramp them up as demand warrants.”

We have a Big Pick Coming. Subscribe Right Now!

Currently running up the charts RBII is an exciting story developing in small caps that is running higher asOxi Thyme “it’s time to clean” gains serious traction. Described by many as the best and most affordable sanitization and disinfectant product on the market – All natural, EPA and CDC approved, Oxi Thyme utilizes an atomizing ULV (ultra-low volume) or HVLP (high volume, low pressure) fogging system which allows droplets of disinfectant to disperse more evenly and cover larger surface areas, creating a no touch solution to sanitize large areas quickly and efficiently leaving no toxic residue. In July RBII reportes significant revenue growth to nearly $350,000 in Q2 as sales and reception of the company’s Oxi Thyme have escalated dramatically. The story has been getting picked up by mainstream press and RBII has started booking significant sales. The Company has been making big moves too recently announcing it is currently in contract negotiations with a health care group with over 300 facilities and involved in talks with several grocery retailers. We will be updating on RBII when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with RBII.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in RBII either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.